Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,026 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
Saeki H, Akiyama M, Abe M, Igarashi A, Imafuku S, Ohya Y, Katoh N, Kameda H, Kabashima K, Tsunemi Y, Hide M, Ohtsuki M; Committee for reviewing the Safety of Atopic Dermatitis/Urticaria Treatment, Japanese Dermatological Association. Saeki H, et al. Among authors: igarashi a. J Dermatol. 2023 Jan;50(1):e1-e19. doi: 10.1111/1346-8138.16635. Epub 2022 Nov 22. J Dermatol. 2023. PMID: 36412059
Coexistence of morphea and systemic sclerosis.
Soma Y, Tamaki T, Kikuchi K, Abe M, Igarashi A, Takehara K, Ishibashi Y. Soma Y, et al. Among authors: igarashi a. Dermatology. 1993;186(2):103-5. doi: 10.1159/000247317. Dermatology. 1993. PMID: 8428037
Japanese guidance for use of biologics for psoriasis (the 2013 version).
Ohtsuki M, Terui T, Ozawa A, Morita A, Sano S, Takahashi H, Komine M, Etoh T, Igarashi A, Torii H, Asahina A, Nemoto O, Nakagawa H; Biologics Review Committee of the Japanese Dermatological Association. Ohtsuki M, et al. Among authors: igarashi a. J Dermatol. 2013 Sep;40(9):683-95. doi: 10.1111/1346-8138.12239. J Dermatol. 2013. PMID: 24033880
Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.
Asahina A, Etoh T, Igarashi A, Imafuku S, Saeki H, Shibasaki Y, Tomochika Y, Toyoizumi S, Nagaoka M, Ohtsuki M; study investigators. Asahina A, et al. Among authors: igarashi a. J Dermatol. 2016 Aug;43(8):869-80. doi: 10.1111/1346-8138.13258. Epub 2016 Feb 15. J Dermatol. 2016. PMID: 26875540 Free PMC article. Clinical Trial.
1,026 results